Edotreotide
Edotreotide
Edotreotide (pronounced as eh-doh-TREE-oh-tide) is a synthetic peptide used in the medical field, particularly in the diagnosis and treatment of certain types of tumors.
Etymology
The term "Edotreotide" is derived from the combination of the words "Edo", which is an abbreviation for the chemical element Erbium, and "treotide", which is a suffix commonly used in the naming of synthetic peptides.
Definition
Edotreotide is a synthetic octreotide analogue that is radiolabeled with Gallium-68 for use in positron emission tomography (PET) imaging. It is primarily used in the diagnosis and treatment of neuroendocrine tumors.
Usage
Edotreotide binds to somatostatin receptors, which are often overexpressed in certain types of tumors. This allows for the imaging and treatment of these tumors. The compound is administered intravenously and is used in conjunction with PET imaging to provide detailed images of the tumors.
Related Terms
- Octreotide: A synthetic peptide that mimics natural somatostatin. It is used in the treatment of acromegaly and certain types of tumors.
- Somatostatin: A hormone that inhibits the release of growth hormone and insulin. It is often overexpressed in certain types of tumors.
- Gallium-68: A radioactive isotope of gallium that is used in PET imaging.
- Positron Emission Tomography (PET): A type of imaging test that uses a radioactive substance to look for disease in the body.
External links
- Medical encyclopedia article on Edotreotide
- Wikipedia's article - Edotreotide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski